Trial
NCT06619015
Tailoring Obesity Treatment Trial
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Collaborators
—
Condition
Obesity
Intervention
Pramlintide Acetate 1 MG/ML
Why stopped
suspended by the danish medical agency
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-17